skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol

Review

(3005) Views  (797) Full article downloads

Authors: Eric A Harris, David A Lubarsky, Keith A Candiotti

Published Date December 2009 Volume 2009:5 Pages 949 - 959
DOI: http://dx.doi.org/10.2147/TCRM.S5583

Eric A Harris, David A Lubarsky, Keith A Candiotti

Department of Anesthesiology, Perioperative Management, and Pain Medicine, University of Miami/Miller School of Medicine

Abstract: Fospropofol, a phosphorylated prodrug version of the popular induction agent propofol, is hydrolyzed in vivo to release active propofol, formaldehyde, and phosphate. Pharmacodynamic studies show fospropofol provides clinically useful sedation and EEG/bispectral index suppression while causing significantly less respiratory depression than propofol. Pain at the injection site, a common complaint with propofol, was not reported with fospropofol; the major patient complaint was transitory perianal itching during the drug’s administration. Although many clinicians believe fospropofol can safely be given by a registered nurse, the FDA mandated that fospropofol, like propofol, must be used only in the presence of a trained anesthesia provider.

Keywords: fospropofol, propofol, monitored anesthesia care








Readers of this article also read:

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Maintenance treatment with infliximab for the management of Crohn’s disease in adults
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Profile of etravirine for the treatment of HIV infection
Update on dexmedetomidine: use in nonintubated patients requiring sedation for surgical procedures
Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
Methemoglobinemia due to topical pharyngeal anesthesia during endoscopic procedures